Cite
HARVARD Citation
Lebwohl, M. et al. (2021). Three‐year U.S. pharmacovigilance report of brodalumab. Dermatologic therapy. 34 (6), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lebwohl, M. et al. (2021). Three‐year U.S. pharmacovigilance report of brodalumab. Dermatologic therapy. 34 (6), p. n/a. [Online].